Logo-bi
Original Research

1. An update to DNA ladder assay for apoptosis detection
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar ORCID
Bioimpacts. 2015;5(1): 25-28. doi: 10.15171/bi.2015.01
PMCID: PMC4401164     PMID: 25901294     Scopus ID: 84924904679    
Article
PDF
XML
Cited By:
139
35
75
Original Research

2. To detect potential pathways and target genes in infantile Pompe patients using computational analysis
Aynur Karadağ Gürel* ORCID, Selçuk Gürel ORCID
BioImpacts. 2022;12(2): 89-105. doi: 10.34172/bi.2022.23467
PMCID: PMC8905584     PMID: 35411297     Scopus ID: 85127154960    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
4
0
6
As a result, it suggests that the enriched genes and new pathways emerging as a result of the analysis may help identify the group that responds poorly to treatment and the outcome of the treatment.
Original Article

3. Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity
Sanya Haiaty ORCID, Mohammad-Reza Rashidi, Maryam Akbarzadeh, Ahad Bazmany, Mostafa Mostafazadeh, Saba Nikanfar, Roya Shabkhizan, Rostam Rezaeian, Reza Rahbarghazi* ORCID, Mohammad Nouri
Bioimpacts. 2023;13(5): 405-413. doi: 10.34172/bi.2022.24208
PMCID: PMC10509738     PMID: 37736340     Scopus ID: 85172786250    
Article
PDF
Full Text
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge